Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Xbrane Biopharma - Filing #702449

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
183 226 SEK
218 126 SEK
Profit (loss) from discontinued operations
5 150 SEK
7 900 SEK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities, discontinued operations
10 401 SEK
8 020 SEK
Cash flows from (used in) operating activities
219 610 SEK
238 407 SEK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities, discontinued operations
352,000 SEK
Cash flows from (used in) investing activities
77 350 SEK
3 855 SEK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities, discontinued operations
529,000 SEK
2 367 SEK
Cash flows from (used in) financing activities
349 365 SEK
322 724 SEK
Increase (decrease) in cash and cash equivalents, discontinued operations
1 758 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.